These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14624323)

  • 1. Validity of performance indicators for assessing prescribing quality: the case of asthma.
    Pont LG; Denig P; van der Molen T; van der Veen WJ; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 2004 Jan; 59(11):833-40. PubMed ID: 14624323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of indicators assessing the quality of drug prescribing for asthma.
    Veninga CC; Denig P; Pont LG; Haaijer-Ruskamp FM
    Health Serv Res; 2001 Apr; 36(1 Pt 1):143-61. PubMed ID: 11324741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suboptimal use of inhaled corticosteroids in children with persistent asthma: inadequate prescription, poor drug adherence, or both?
    Pando S; Lemière C; Beauchesne MF; Perreault S; Forget A; Blais L
    Pharmacotherapy; 2010 Nov; 30(11):1109-16. PubMed ID: 20973684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic asthma: attendance and prescribing in general practice.
    Nolan D; White R
    Respir Med; 2002 Feb; 96(2):102-9. PubMed ID: 11860166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How appropriate is asthma therapy in general practice?
    Laforest L; Pacheco Y; Bousquet J; Kocevar VS; Yin D; Van Ganse E
    Fundam Clin Pharmacol; 2005 Feb; 19(1):107-15. PubMed ID: 15660967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structuring prescribing data into traffic-light categories; a tool for evaluating treatment quality in primary care.
    Lagerløv P; Hjortdahl P; Saxegaard L; Andrew M; Matheson I
    Fam Pract; 2001 Oct; 18(5):528-33. PubMed ID: 11604377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy-specific quality indicators for asthma therapy.
    Winterstein AG; Hartzema AG
    Res Social Adm Pharm; 2005 Sep; 1(3):430-45. PubMed ID: 17138488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity from asthma in relation to regular treatment: a community based study.
    Walsh LJ; Wong CA; Cooper S; Guhan AR; Pringle M; Tattersfield AE
    Thorax; 1999 Apr; 54(4):296-300. PubMed ID: 10092689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial.
    Rottenkolber M; Fischer R; Ibáñez L; Fortuny J; Reynolds R; Amelio J; Gerlach R; Tauscher M; Thürmann P; Hasford J; Schmiedl S
    BMC Pulm Med; 2015 May; 15():55. PubMed ID: 25943421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed postal feedback about prescribing to asthma patients combined with a guideline statement showed no impact: a randomised controlled trial.
    Søndergaard J; Andersen M; Vach K; Kragstrup J; Maclure M; Gram LF
    Eur J Clin Pharmacol; 2002 May; 58(2):127-32. PubMed ID: 12012145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obtaining optimal control in mild asthma: theory and practice.
    Watson L; Kerstjens HA; Rabe KF; Kiri V; Visick GT; Postma DS
    Fam Pract; 2005 Jun; 22(3):305-10. PubMed ID: 15805133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma.
    Bijl-Hofland ID; Cloosterman SG; Folgering HT; van den Elshout FJ; van Weel C; van Schayck CP
    Am J Respir Crit Care Med; 2001 Sep; 164(5):764-9. PubMed ID: 11549530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it possible to measure prescribing quality using only prescription data?
    Andersen M
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):314-9. PubMed ID: 16611208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of prescribing indicators for assessing quality of antibiotic use in Australian general practice.
    Pont LG; Morgan TK; Williamson M; Haaijer FM; van Driel ML
    Int J Pharm Pract; 2017 Feb; 25(1):66-74. PubMed ID: 27774679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of inhalation therapy in bronchial asthma in adults above twelve years of age in armed forces.
    Barthwal MS; Deoskar RB; Rajan KE
    J Assoc Physicians India; 2005 Aug; 53():681-4. PubMed ID: 16398075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
    MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Hong Kong doctors following the Global Initiative for Asthma guidelines: a questionnaire "Survey on Asthma Management"?
    Ko FW; Chan AM; Chan HS; Kong AY; Leung RC; Mok TY; Tse HH; Lai CK
    Hong Kong Med J; 2010 Apr; 16(2):86-93, quiz 5 p following 893. PubMed ID: 20354241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.
    Sadatsafavi M; Lynd LD; Marra CA; FitzGerald JM
    Thorax; 2014 Apr; 69(4):328-34. PubMed ID: 24281327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Medicaid patients with asthma: comparison with treatment guidelines using disease-based drug utilization review methodology.
    Laumann JM; Bjornson DC
    Ann Pharmacother; 1998 Dec; 32(12):1290-4. PubMed ID: 9876808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.